Poliomyelitis (Post-polio)

Post-polio syndrome is a neurological condition characterized by new muscle weakness, fatigability, generalized fatigue, and pain occurring typically ≥15 years after the initial paralytic poliomyelitis illness, affecting an estimated 29–42% of paralytic polio survivors. [1-2] It is a diagnosis of exclusion with no specific confirmatory test. [1][3]

• Confirm prior paralytic poliomyelitis: age at onset, severity, limbs involved, hospitalization, ventilator use [3]
• Establish the stable interval: period of functional recovery and neurological stability (typically ≥15 years) before new symptoms [2-3]
• Characterize the classic triad: new weakness, fatigue, and pain — onset gradual or sudden (e.g., after surgery, trauma, or inactivity) [3]
• Fatigue characterization: distinguish generalized/flu-like exhaustion (worse as day progresses) vs. focal muscle fatigability vs. cognitive/"postpolio wall" fatigue [1][4]
• Pain characterization: muscular aching/cramping (often in polio-affected limbs, activity-related, end-of-day), joint pain, myofascial pain vs. neuropathic pain [1]
• Ask about dysphagia, dysphonia, choking episodes (bulbar involvement) [1]
• Ask about respiratory symptoms: dyspnea on exertion, orthopnea, morning headaches, excessive daytime somnolence, snoring, poor sleep quality [1][3]
• Cold intolerance, muscle cramps, fasciculations [1]
• Important negatives: no upper motor neuron signs (spasticity, hyperreflexia, Babinski), no sensory loss in a dermatomal pattern, no rapid progression suggesting ALS

• Acute respiratory failure or worsening hypoventilation — especially in patients with prior respiratory polio, scoliosis, or obesity [1][3]
• New dysphagia with aspiration risk — up to 10–20% of PPS patients have swallowing dysfunction, even without prior bulbar involvement [5]
• Rapid, precipitous weakness — atypical for PPS (usually slow/gradual); should prompt evaluation for ALS, CIDP, or other neuromuscular disease [1][6]
• Acute weakness after surgery/anesthesia — PPS patients have increased sensitivity to anesthetic agents and neuromuscular blockers [5][7]
• Falls with fractures — osteoporosis and gait instability are common; fracture risk is elevated [2]
• Cor pulmonale signs (peripheral edema, JVD) in patients with chronic hypoventilation [8]

• No proven disease-modifying pharmacotherapy exists for PPS [2][6]
• Medications studied without clear benefit: amantadine, high-dose prednisone, modafinil (two RCTs negative for fatigue), pyridostigmine (conflicting results), coenzyme Q10 [3]
• IVIg: reduced CSF proinflammatory cytokines and showed variable clinical effects in RCTs; not recommended for routine use at present [3][6]
• Lamotrigine: one controlled study showed promising results for pain, fatigue, and quality of life [3]
• Symptomatic treatments:
  • Analgesics (acetaminophen, NSAIDs) for musculoskeletal pain
  • Dopamine agonists for restless legs syndrome (prevalence ~36% in PPS) [1][3]
  • Antidepressants for comorbid depression and chronic pain
• Medications to use with caution:
  • Succinylcholine — risk of hyperkalemia; avoid [5]
  • Nondepolarizing muscle relaxants — use at reduced doses due to increased sensitivity [5]
  • Sedative-hypnotics and opioids — may worsen respiratory dysfunction; use cautiously [5]

• Weight management is critical — excess weight increases biomechanical stress on weakened muscles and joints and worsens respiratory function [2][6]
• Obesity contributes to sleep-disordered breathing and increased energy cost of ambulation [1][8]
• No specific dietary triggers; standard balanced nutrition with adequate protein to support muscle maintenance
• Ensure adequate vitamin D and calcium intake given osteoporosis risk from disuse and immobility
• Address dysphagia-related dietary modifications (texture modification, thickened liquids) if bulbar involvement is present [1]

• Neurological: new weakness pattern, fasciculations, muscle cramps, cold intolerance, cognitive fatigue
• Respiratory: dyspnea, orthopnea, morning headaches, daytime somnolence, snoring [3]
• GI/Swallowing: dysphagia, choking, voice changes (dysphonia) [1]
• Sleep: insomnia, restless legs, excessive daytime sleepiness, witnessed apneas [1][8]
• Musculoskeletal: joint pain, back pain, new deformities, gait changes
• Psychiatric: depression, anxiety, adjustment difficulties — many polio survivors have difficulty accepting functional decline [2][9]
• Urological: bladder dysfunction may occur in some patients

• Collateral: Confirm original polio diagnosis (childhood records, vaccination history, country of origin); many patients from 1940s–1950s epidemics may lack documentation
• Functional baseline from family/caregivers — what could the patient do 1, 5, 10 years ago vs. now?
• Caregiver burden assessment
• Family history: PPS is not hereditary, but family history of neurodegenerative disease (ALS, muscular dystrophy) should be explored to exclude mimics [1]
• Social context: occupational demands, home accessibility, assistive device use, social isolation

• Severity of initial paralytic poliomyelitis — greater initial involvement predicts earlier and more severe PPS [4]
• Greater degree of recovery after acute polio (paradoxically, those who recovered more may have more enlarged motor units at risk of decompensation) [10]
• Older age at onset of acute polio
• Female sex may have higher prevalence, though men show greater rate of strength decline over time [6]
• Physical overuse of weakened muscles over decades [2]
• Weight gain and deconditioning [2][6]
• Scoliosis — contributes to respiratory compromise and OSA progression [3][11]
• Comorbidities: obesity, sleep apnea, depression, osteoarthritis, osteoporosis

PPS is a diagnosis of exclusion. Key alternative diagnoses to consider: [1]

• ALS (amyotrophic lateral sclerosis) — upper AND lower motor neuron signs; more rapid progression; fasciculations may overlap but UMN signs distinguish
• Inclusion body myositis — progressive proximal and distal weakness (especially finger flexors, knee extensors); elevated CK; muscle biopsy diagnostic
• CIDP (chronic inflammatory demyelinating polyneuropathy) — sensory involvement, areflexia, elevated CSF protein, demyelinating NCS pattern
• Lumbar spinal stenosis — neurogenic claudication mimicking leg weakness/fatigue with ambulation [1]
• Polymyalgia rheumatica — proximal limb aching/stiffness, elevated ESR/CRP; common in older adults and may mimic PPS [1]
• Fibromyalgia — diffuse pain and fatigue; prevalence ~10.5% in post-polio clinic populations [4]
• Peripheral vascular disease — vascular claudication limiting mobility [1]
• Thyroid dysfunction, anemia, vitamin deficiencies — treatable causes of fatigue [1]
• Depression — significant contributor to fatigue and pain in PPS [1]
• Radiculopathy/myelopathy — superimposed spinal pathology

• Original polio episode: age, severity, limbs affected, bulbar involvement, respiratory support needed, duration of recovery
• Surgical history: prior orthopedic procedures (tendon transfers, arthrodesis, limb-lengthening), spinal surgery
• Chronic conditions: osteoarthritis (accelerated by biomechanical abnormalities), osteoporosis, scoliosis, carpal tunnel syndrome, ulnar neuropathy [1]
• Prior anesthesia experiences — any prolonged recovery or respiratory complications [5][7]
• Assistive device history: braces, orthotics, canes, wheelchairs — and any recent changes in need

• Vital signs: SpO2 (especially supine), respiratory rate, BMI
• Neurological exam:
  • Motor: document strength in all limbs (MRC grading); compare polio-affected vs. "unaffected" limbs; look for new atrophy, fasciculations
  • Reflexes: typically diminished or absent in affected limbs (LMN pattern); presence of hyperreflexia or Babinski sign should raise concern for alternative diagnosis
  • Sensory: should be normal in PPS; abnormalities suggest alternative or superimposed pathology
• Musculoskeletal: joint deformities, limb-length discrepancy, scoliosis, contractures, gait analysis
• Respiratory: chest wall excursion, paradoxical breathing, accessory muscle use; assess for kyphoscoliosis
• Bulbar: palatal movement, gag reflex, voice quality, tongue atrophy/fasciculations
• Gait: observe for compensatory patterns, Trendelenburg sign, foot drop, need for assistive devices
• Skin: check for pressure injuries in patients with reduced mobility

• Baseline labs to exclude mimics: [1]
  • CBC (anemia)
  • TSH (thyroid dysfunction)
  • CMP (renal/hepatic disease, electrolytes)
  • Fasting glucose/HbA1c (diabetes)
  • Vitamin B12, folate, vitamin D
  • ESR/CRP (inflammatory conditions, polymyalgia rheumatica)
  • Iron studies (iron deficiency contributing to fatigue/RLS)
• CK: may be mildly elevated in polio survivors but is not specific for PPS and cannot distinguish PPS from non-PPS polio survivors [1][3]
• ABG: if respiratory compromise suspected (vital capacity <55% predicted) [4]
• CSF analysis: rarely needed; may show inflammatory markers; primarily a research tool [1]

• Not routinely required for PPS diagnosis
• X-rays: spine (scoliosis assessment), affected joints (osteoarthritis, deformities), limb-length discrepancy
• MRI spine: if radiculopathy, myelopathy, or spinal stenosis suspected [1]
• Vascular duplex studies: if peripheral vascular disease/claudication is a concern [1]
• Chest X-ray: if respiratory symptoms present; assess for cardiomegaly, scoliosis
• Muscle MRI: may show fatty infiltration of muscles; not routinely indicated but can help characterize extent of involvement

• EMG/Nerve Conduction Studies (NCS): the most important ancillary test [1][3]
  • Confirms prior anterior horn cell disease (chronic neurogenic changes: large motor unit potentials, reduced recruitment, fibrillation potentials indicating ongoing denervation)
  • Cannot reliably distinguish PPS from stable post-polio, but helps exclude other neuromuscular disorders (CIDP, ALS, myopathy) [1]
  • Macro-EMG can quantify remaining motor units and their size [3]
  • 5% of patients with confirmed polio history may have normal EMG [3]
• Pulmonary function tests (PFTs): spirometry (sitting and supine); if vital capacity <50–55% predicted, obtain full PFTs and ABG [4-5]
• Polysomnography: indicated for symptoms of sleep-disordered breathing, excessive daytime somnolence, or morning headaches; three patterns identified — obstructive sleep apnea, hypoventilation, or mixed [8][12]
• Swallowing evaluation: video fluoroscopy/modified barium swallow if dysphagia present [4]
• Muscle biopsy: rarely needed; shows fiber type grouping (chronic reinnervation) and small angulated fibers (active denervation); primarily to exclude inclusion body myositis or other myopathies [1]

• Not a primary diagnostic tool for PPS, but should be obtained as part of general evaluation in older patients
• Assess for cor pulmonale (right axis deviation, right ventricular hypertrophy, P pulmonale) in patients with chronic respiratory insufficiency [8]
• Rule out cardiac causes of fatigue and dyspnea
• Consider echocardiography if cardiac disease suspected

Post-polio syndrome is a slowly progressive neurodegenerative condition resulting from ongoing denervation that eventually exceeds the capacity for compensatory reinnervation. [1][10] The classic presentation is the triad of new weakness, fatigue, and pain after a stable interval of ≥15 years following acute paralytic polio. [3]

• Severity stratification: ranges from mild (fatigue, pain with preserved function) to severe (progressive weakness with respiratory compromise, dysphagia, wheelchair dependence)
• Atypical presentations: symptoms may occur in limbs thought to be unaffected during acute polio (subclinical involvement is common); patients with non-paralytic polio can also develop PPS [3]
• Complications: respiratory failure, aspiration pneumonia, falls/fractures, chronic pain, depression, social isolation, progressive immobility [1][3][9]
• Annual muscle strength decline: typically 1–3%/year, with 9–15% decline over 8 years; some patients may lose 5–8%/year [2][6]

No curative treatment exists; management is multidisciplinary rehabilitation-focused. [2-3][6]

• Energy conservation and pacing: activity modification, scheduled rest periods, work simplification techniques — the mainstay of treatment [3][6]
• Exercise prescription (individualized, physiotherapist-supervised): [2-3]
  • Moderate-intensity strengthening and aerobic exercise can improve function
  • Avoid overuse of weakened muscles; monitor for worsening weakness or pain
  • Aquatic therapy is beneficial — reduces biomechanical stress [2]
• Orthotic management: lightweight carbon-fiber AFOs/KAFOs to reduce energy cost of walking; evaluate for assistive devices (canes, walkers, wheelchairs, scooters) [2][6]
• Respiratory support: noninvasive ventilation (BiPAP/NIV) for nocturnal hypoventilation; CPAP for obstructive sleep apnea [8][12-13]
• Pain management: targeted to etiology — NSAIDs/acetaminophen for musculoskeletal pain; physical therapy; consider lamotrigine for neuropathic-type pain; address psychosocial contributors [1][3]
• Dysphagia management: speech-language pathology evaluation; dietary modifications; swallowing strategies [4]
• Psychological support: counseling for adjustment difficulties, depression screening and treatment [2][9]
• Weight management: reduce biomechanical demands and respiratory burden [2][6]
• Anesthesia precautions (for any surgical procedure): [5][7]
  • Avoid succinylcholine (hyperkalemia risk)
  • Reduce doses of nondepolarizing muscle relaxants
  • Minimize sedatives/opioids
  • Preoperative PFTs; plan for possible prolonged postoperative ventilatory support
  • Neuraxial anesthesia generally considered safe but use with awareness of increased neural sensitivity [5][14]

• Outpatient management is appropriate for the vast majority of PPS patients
• Admission criteria:
  • Acute respiratory failure or significant hypoventilation requiring ventilatory support initiation
  • Aspiration pneumonia
  • Acute functional decline requiring inpatient rehabilitation
  • Perioperative management in patients with significant respiratory compromise
• Observation: new-onset respiratory symptoms with borderline PFTs pending sleep study/ABG results
• Specialist consultation triggers:
  • Neurology/Physiatry: for diagnosis confirmation, EMG, and rehabilitation planning
  • Pulmonology: respiratory symptoms, PFT abnormalities, sleep-disordered breathing
  • Orthopedics: joint deformities, scoliosis progression, fractures
  • Speech-language pathology: dysphagia, dysphonia
  • Psychology/Psychiatry: depression, adjustment disorders

• Follow-up timing: every 6–12 months with neurology or physiatry for strength monitoring and rehabilitation adjustment; more frequently if actively declining [6]
• PFTs: annual if respiratory involvement; more frequently if vital capacity declining
• Symptoms requiring immediate reassessment:
  • Acute worsening of weakness (especially if rapid — consider alternative diagnosis)
  • New or worsening dyspnea, orthopnea, morning headaches
  • Choking episodes or aspiration events
  • Falls or inability to perform previously manageable activities
• Patient counseling points:
  • PPS is slowly progressive with periods of stability that may last years [6]
  • Progressive symptoms should not be automatically attributed to PPS — new symptoms warrant reevaluation [1]
  • Balance activity with rest; avoid both overuse and complete inactivity [3]
  • An active lifestyle with appropriate modifications is associated with better well-being [6]
• Expected course: gradual functional decline over years to decades; majority experience modest decline in physical mobility, though ~20% may have more substantial decline in walking capacity over 20 years [6]

1. Postpolio syndrome and the late effects of poliomyelitis. Part 1. pathogenesis, biomechanical considerations, diagnosis, and investigations. — Lo JK, Robinson LR. Muscle & Nerve. 2018.

2. Treatment for Postpolio Syndrome. — Koopman FS, Beelen A, Gilhus NE, de Visser M, Nollet F. The Cochrane Database of Systematic Reviews. 2015.

3. Management of Postpolio Syndrome. — Gonzalez H, Olsson T, Borg K. The Lancet. Neurology. 2010.

4. Post‐poliomyelitis syndrome. — Trojan DA, Cashman NR. Muscle & Nerve. 2005.

5. Neuromuscular disease and anesthesia. — Romero A, Joshi GP. Muscle & Nerve. 2013.

6. Post‐polio syndrome and the late effects of poliomyelitis: Part 2. treatment, management, and prognosis. — Lo JK, Robinson LR. Muscle & Nerve. 2018.

7. Postpolio Syndrome and Anesthesia. — Lambert DA, Giannouli E, Schmidt BJ. Anesthesiology. 2005.

8. "Postpolio" Sequelae and Sleep-Related Disordered Breathing. — Hsu AA, Staats BA. Mayo Clinic Proceedings. 1998.

9. Post-Polio Syndrome: More Than Just a Lower Motor Neuron Disease. — Li Hi Shing S, Chipika RH, Finegan E, et al. Frontiers in Neurology. 2019.

10. The Post-Polio Syndrome as an Evolved Clinical Entity. Definition and Clinical Description. — Dalakas MC. Annals of the New York Academy of Sciences. 1995.

11. Obstructive Sleep Apnea in Community-Dwelling Polio Survivors: A 5-Year Longitudinal Follow-Up Study. — Ding Q, Li X, Wang M, et al. Frontiers in Neurology. 2025.

12. Sleep in Postpolio Syndrome. — Steljes DG, Kryger MH, Kirk BW, Millar TW. Chest. 1990.

13. Sleep-Disordered Breathing in Neuromuscular Disease: Diagnostic and Therapeutic Challenges. — Aboussouan LS, Mireles-Cabodevila E. Chest. 2017.

14. A Patient With Postpolio Syndrome Developed Cauda Equina Syndrome After Neuraxial Anesthesia: A Case Report. — Tseng WC, Wu ZF, Liaw WJ, Hwa SY, Hung NK. Journal of Clinical Anesthesia. 2017.